{"denoms":[{"counts":[{"groupId":"BG000","value":"78"},{"groupId":"BG001","value":"39"},{"groupId":"BG002","value":"117"}],"units":"Participants"}],"groups":[{"description":"Participants received oral dose of everolimus 4.5 mg/m\\^2 daily as an initial starting dose to attain the whole blood trough concentrations in range of 5-15 ng/mL. Dose adjustments were permitted based on safety and whole blood trough concentrations.","id":"BG000","title":"Everolimus (Core Period)"},{"description":"Participants received oral dose of placebo matching to everolimus daily.","id":"BG001","title":"Placebo (Core Period)"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"5.9","value":"10.1"},{"groupId":"BG001","spread":"7.3","value":"10.3"},{"groupId":"BG002","spread":"6.4","value":"10.2"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"20"}]}],"title":"<3 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"55"},{"groupId":"BG001","value":"26"},{"groupId":"BG002","value":"81"}]}],"title":"3-18 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"16"}]}],"title":"≥18 years"}],"paramType":"NUMBER","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29"},{"groupId":"BG001","value":"21"},{"groupId":"BG002","value":"50"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"49"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"67"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}